Sign in to view content

2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

Nancy M. Holekamp, MD, FASRS

Video
Published 2018

Related

Progression of diabetic retinopathy in patients treated with 0.2 μg/day
Raymond Iezzi, MD, MS
Updates from the Field
2017
OCT Angiography (OCTA) Monitors The Influence of Different VEGF-I Drugs on a Specific CNVM
Anne M. Hanneken, MD
Annual Meeting Talks
2018
2019 Winning Pitch Challenge Winner
Updates from the Field

Category: Diabetic Retinopathy

See more